Area of research
Rheumatology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Colorectal cancer and Single-nucleotide polymorphism, with related work in MTRR, Observational study, Methylenetetrahydrofolate reductase. Notable publications include 'Plasma Choline Metabolites and Colorectal Cancer Risk in the Women's Health Initiative Observational Study', 'Homocysteine, cysteine, and risk of incident colorectal cancer in the Women’s Health Initiative observational cohort', and 'Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers'.
Folate‐mediated one‐carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: <scp>W</scp>omen's <scp>H</scp>ealth <scp>I</scp>nitiative <scp>O</scp>bservational <scp>S</scp>tudy
Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study
Plasma Choline Metabolites and Colorectal Cancer Risk in the Women's Health Initiative Observational Study
Biomarkers of One-Carbon Metabolism Are Associated with Biomarkers of Inflammation in Women
Relationship between plasma choline metabolites and risk of colorectal cancer in the Women's Health Initiative Observational Study (370.5)
Abstract 2197: Interaction between genetic variants in one-carbon metabolism and folate biomarkers on colorectal cancer risk: The Women's Health Initiative observational cohort
Abstract 2186: Inflammation- and angiogenesis- related genes: Interaction with NSAID use, and serum inflammatory markers on colorectal cancer risk within the Women's Health Initiative
Homocysteine, cysteine, and risk of incident colorectal cancer in the Women’s Health Initiative observational cohort
Impact of folic acid fortification on global DNA methylation and one-carbon biomarkers in the Women's Health Initiative Observational Study cohort
Relationship between leukocyte global DNA methylation and RBC folate in the Women's Health Initiative Observational Study (WHI‐OS)
Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers